関連する実験動画
Updated: Jul 31, 2026

07:52
Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
Published on: June 2, 2015
缺血性予備条件付けとベータアドレナジック信号伝導経路
1Department of Medical Physiology and Biochemistry, Faculty of Medicine, University of Stellenbosch, MRC Experimental Biology Programme, Tygerberg, Republic of South Africa. alo@gerga.sun.ac.za
Circulation
|September 1, 1999
まとめ
前条件付け中のベータアドレナージ信号活性化は,循環性アデノシンモノフォスファート (cAMP) 増加によって示され,心筋膜の保護を誘発する. この経路を遮断すると,保護が弱くなり,アゴニストは保護を誘発し,その重要な役割を強調する.
科学分野:
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
- 生理学 生理学とは
背景:
- 以前の研究では,プリコンディショニング (PC) プロトコル中に組織サイクルアデノシンモノフォスファート (cAMP) の周期的増加を示していた.
- 持続したイシュケミアは,cAMPの蓄積を弱め,β-アドレナージ信号伝達経路の調査を促した.
研究 の 目的:
- ベータ・アドレナジックシグナル伝達経路のイシュケミア誘発の活性化が心臓保護を誘発するかどうかを判断する.
- プリコンディショニングの誘発におけるcAMP生成の役割を明らかにする.
主な方法:
- 隔離されたパルフューズされたラットの心臓は,予備条件付け (3x5分グローバル・イシュケミア,5分再注射) を受けました.
- ベータ・アドレナジック反応は,cAMP生成後アゴニスト投与で評価された.
- 組織におけるcAMP,アデニルサイクラゼ,タンパク質キナーゼA (PKA) 活性,ベータアドレナージック受容体の特徴を測定した.
- リパーフュージョン中の機能回復は,cAMP増加を阻害または誘導した後で評価されました.
主要な成果:
- 断続性イシュケミアはベータアドレナジックへの反応性を低下させ,アデニリルサイクラゼおよびPKAの活性性を増加させた.
- cAMPを阻害すると,弱体化された心筋膜の保護が増加し,逆に,アゴニストは保護を誘発する.
- 保護とベータアドレナジック無敏感化との間には直接的な相関は見つかりませんでした.
結論:
- 予備条件付け中のベータアドレナージ信号伝達経路のイシェミア誘発の活性化は,心臓保護のトリガーとして機能します.
- プレコンディショニング効果を誘発するベータアドレナージック経路の役割は重要だ.
関連する概念動画
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

